All 27 participants have been enrolled across three cohorts with the final cohort of eight participants residing at the clinical research facility for the 15-day dosing period. Approximately half of ...
LTR Pharma has recruited all 27 participants for the Phase II clinical study for its SPONTAN nasal spray for the treatment of erectile dysfunction. All 27 participants have been enrolled across three ...
Read LTP's full ASX announcement titled "SPONTAN Phase II Clinical Study Completes Recruitment" from 05 Mar 2026, on Market Index.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results